MR-guided radiation therapy for high-grade brain tumors
Part of Cancer clinical trials.
This study tests a new way to deliver radiation therapy for a type of aggressive brain tumor called glioblastoma or grade 4 astrocytoma. Patients get MRI scans during each treatment so the radiation beam can be adjusted precisely, aiming to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with a glioblastoma or grade 4 astrocytoma (confirmed by biopsy or surgery).
- Your doctor recommends starting standard chemotherapy (temozolomide) along with radiation therapy.
- Your biopsy or surgery was within the last 12 weeks before joining the study.
- You are expected to live at least 12 weeks.
- Your activity level is good (ECOG score 0, 1, or 2, meaning you can care for yourself and walk around).
- Your kidney function is good enough to safely receive a contrast dye used in MRI scans.
- You are able to lie flat for at least 30 minutes and wear a special mask to keep your head still during treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way of using MRI scans to see which parts of a brain tumour are low on oxygen. This could help doctors target radiation therapy more precisely and improve treatment for people with fast-growing brain tumours.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
This study uses repeated MRI scans with a contrast dye to help doctors tailor (adapt) your radiation treatment over time for a high-grade glioma. It may help improve how accurately radiation targets the tumor as it changes.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This trial tests a new way of giving radiation therapy for glioblastoma (a type of brain cancer) using a machine that combines MRI imaging with radiation. The goal is to safely intensify the treatment and improve outcomes.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.